New "Scope" Chemical Space Yields Ligand-Efficient Hits Across Three Targets
- "Scope" describes a mid-sized (10k-50k compound) chemical space positioned between minimal fragments and fully elaborated low-molecular-weight libraries, designed to maximize ligand efficiency and medicinal chemistry tractability.
- The authors introduce "Scope ring systems" (ring-X-ring) as a core organizing concept for building libraries and guiding functionalization toward sufficient potency.
- A 10k-compound Scope screening set — evaluated by SPR, native mass spectrometry, DSF, and biochemical assays — matches general diversity sets' primary hit rates even at higher screening concentrations, while showing superior ligand efficiency and higher hit rates after counter-screening.
- Case studies on trypanosomal CLK1 kinase, a 14-3-3/estrogen receptor-alpha molecular glue project, and SARS-CoV-2 main protease show the set yields diverse, tractable, ligand-efficient hits across varied binding sites.
The "sweet spot between fragments and full libraries" pitch isn't new — DEL, FBDD, and house libraries have all claimed it before. What's actually new in Scope is the ring-X-ring organizing logic: forcing vectors off two ring systems rather than one flat scaffold gives a built-in growth vector for SAR from hit one, the part fragment campaigns usually bolt on later. The number that matters to me isn't the hit rate, it's "higher hit rate after counter-screening" — that's fewer SPR artifacts and aggregators wasting my week. The real test is the 14-3-3/ERα glue case: PPI/glue targets chew up conventional libraries because there's no deep pocket to reward LE. If a rigid, moderately-sized scaffold set can seed a glue hit, that's the transferability claim worth watching, not the Mpro or CLK1 wins.